Qiming co-leads StairMed’s Series B round and 44 Greater China deals worth over $371m

Qiming co-leads StairMed’s Series B round and 44 Greater China deals worth over $371m

23 February, 2025

Edited by: Joymitra Rai

Fountainbridge Capital Lilly Asia Ventures OrbiMed Healthcare Fund Management Oriza Seed Qiming Venture Partners

Printed by Unregistered user on Fri, 22 Aug 2025 16:16:25 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

Venture Capital

Yangzhou Nanopore raises Series A+ round, and 21 Greater China deals worth over $263m

China's SAIC, Huawei join hands to develop new smart EVs

Read more from Greater China

Starbucks expects non-binding bids for China business in two weeks

From $50b to bust, investors count cost of Evergrande’s market tryst